DexCom Valuation
| DXCM Stock | USD 134.56 1.58 1.16% |
At this time, the firm appears to be fairly valued. DexCom Inc shows a prevailing Real Value of $133.98 per share. The current price of the firm is $134.56. Our model computes the value of DexCom Inc from reviewing the firm fundamentals such as Current Valuation of 51.74 B, profit margin of 0.15 %, and Shares Outstanding of 385.52 M as well as analyzing its technical indicators and probability of bankruptcy. In general, most investors advise obtaining undervalued instruments and abandoning overvalued instruments since, at some point, asset prices and their ongoing real values will submerge. Key fundamental drivers impacting DexCom's valuation include:
Price Book 25.3774 | Enterprise Value 51.7 B | Enterprise Value Ebitda 57.124 | Price Sales 14.4891 | Forward PE 77.5194 |
Fairly Valued
Today
Please note that DexCom's price fluctuation is very steady at this time. Calculation of the real value of DexCom Inc is based on 3 months time horizon. Increasing DexCom's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Our valuation method for DexCom Inc is useful when determining the fair value of the DexCom stock, which is usually determined by what a typical buyer is willing to pay for full or partial control of DexCom. Since DexCom is currently traded on the exchange, buyers and sellers on that exchange determine the market value of DexCom Stock. However, DexCom's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 134.56 | Real 133.98 | Target 137.0 | Hype 134.6 |
The real value of DexCom Stock, also known as its intrinsic value, is the underlying worth of DexCom Inc Company, which is reflected in its stock price. It is based on DexCom's financial performance, assets, liabilities, growth prospects, management team, or industry conditions. The intrinsic value of DexCom's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence DexCom's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of DexCom Inc helps investors to forecast how DexCom stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of DexCom more accurately as focusing exclusively on DexCom's fundamentals will not take into account other important factors: Traditionally analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use DexCom's intrinsic value based on its ongoing forecasts of DexCom's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against DexCom's closest peers. When choosing an evaluation method for DexCom Inc, ensure it is appropriate for the firm given its current financial situation and market classification. If more than one evaluation category is relevant, we suggest using both methods to arrive at a better estimate.
DexCom Investments |
|
DexCom Valuation Trend
Knowing DexCom's actual value is paramount for traders to make sound investment determinations. DexCom's real value is not only important for the investor to make better decisions but also for a more accurate overall view of DexCom's financial worth over time since having this information enables investors and analysts to forecast the earnings more efficiently. Using both DexCom's enterprise value as well as its market capitalization is the best way to gauging the value of the company and is usually enough for investors to make market timing descisions.
DexCom Market Cap
DexCom Inc is one of the top stocks in market capitalization category among related companies. Market capitalization of Health Care industry is currently estimated at about 73.43 Billion. DexCom totals roughly 52.49 Billion in market capitalization claiming about 71% of equities under Health Care industry.DexCom Valuation Ratios as Compared to Competition
Comparative valuation techniques use various fundamental indicators to help in determining DexCom's current stock value. Our valuation model uses many indicators to compare DexCom value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across DexCom competition to find correlations between indicators driving DexCom's intrinsic value. More Info.DexCom Inc is one of the top stocks in price to earning category among related companies. It is one of the top stocks in price to book category among related companies fabricating about 0.10 of Price To Book per Price To Earning. The ratio of Price To Earning to Price To Book for DexCom Inc is roughly 9.67 . As of the 16th of April 2024, Price To Book Ratio is likely to grow to 24.31. Comparative valuation analysis is a catch-all model that can be used if you cannot value DexCom by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for DexCom's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the DexCom's earnings, one of the primary drivers of an investment's value.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates DexCom's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in DexCom and how it compares across the competition.
About DexCom Valuation
The stock valuation mechanism determines the current worth of DexCom Inc on a weekly basis. We use both absolute as well as relative valuation methodologies to arrive at the intrinsic value of DexCom Inc. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of DexCom Inc based exclusively on its fundamental and basic technical indicators. By analyzing DexCom's financials, quarterly and monthly indicators, and its related drivers such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of DexCom's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of DexCom. We calculate exposure to DexCom's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to DexCom's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 2.3 B | 2.4 B | |
| Pretax Profit Margin | 0.20 | 0.21 | |
| Operating Profit Margin | 0.17 | 0.17 | |
| Net Profit Margin | 0.15 | 0.16 | |
| Gross Profit Margin | 0.63 | 0.66 |
8 Steps to conduct DexCom's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates DexCom's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct DexCom's valuation analysis, follow these 8 steps:- Gather financial information: Obtain DexCom's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine DexCom's revenue streams: Identify DexCom's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research DexCom's industry and market trends, including the size of the market, growth rate, and competition.
- Establish DexCom's growth potential: Evaluate DexCom's management, business model, and growth potential.
- Determine DexCom's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate DexCom's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
DexCom Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines. Note, investing in growth stocks can be very risky. If the company such as DexCom does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 425.5 M | |
| Quarterly Earnings Growth Y O Y | 1.81 | |
| Forward Price Earnings | 77.5194 |
DexCom Current Valuation Indicators
Valuation refers to the process of determining the present value of DexCom Inc and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value DexCom we look at many different elements of the entity such as DexCom's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation. DexCom's valuation analysis is also a process of estimating the intrinsic value of all assets and outstanding equities. There are different methodologies and models we use to develop the final DexCom's valuation. The techniques such as discounted cash flow and fundamental indicators such as book value per share or market capitalization are well known and widely used across most financial advisers and money managers.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as DexCom, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use DexCom's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes DexCom's worth.When determining whether DexCom Inc is a strong investment it is important to analyze DexCom's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact DexCom's future performance. For an informed investment choice regarding DexCom Stock, refer to the following important reports: Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in DexCom Inc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in main economic indicators. Note that the DexCom Inc information on this page should be used as a complementary analysis to other DexCom's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.
Complementary Tools for DexCom Stock analysis
When running DexCom's price analysis, check to measure DexCom's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy DexCom is operating at the current time. Most of DexCom's value examination focuses on studying past and present price action to predict the probability of DexCom's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move DexCom's price. Additionally, you may evaluate how the addition of DexCom to your portfolios can decrease your overall portfolio volatility.
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules |
Is DexCom's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of DexCom. If investors know DexCom will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about DexCom listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 1.81 | Earnings Share 1.31 | Revenue Per Share 9.384 | Quarterly Revenue Growth 0.269 | Return On Assets 0.0641 |
The market value of DexCom Inc is measured differently than its book value, which is the value of DexCom that is recorded on the company's balance sheet. Investors also form their own opinion of DexCom's value that differs from its market value or its book value, called intrinsic value, which is DexCom's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because DexCom's market value can be influenced by many factors that don't directly affect DexCom's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between DexCom's value and its price as these two are different measures arrived at by different means. Investors typically determine if DexCom is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, DexCom's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.